Skip to content

Therapeutic Effect of Acupoint Catgut Embedding Combined with Scalp Acupuncture on the Sequelae of Facial Paralysis

Therapeutic Effect of Acupoint Catgut Embedding Combined with Scalp Acupuncture on the Sequelae of Facial Paralysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000437
Enrollment
Unknown
Registered
2026-03-03
Start date
2024-02-19
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sequelae of Facial Paralysis

Interventions

Control group:Acupoint Catgut Embedding
Experimental group:Acupoint Catgut Embedding Combined with Scalp Acupuncture

Sponsors

Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for peripheral facial paralysis as defined by both traditional Chinese medicine and Western medicine; (2) Age ranging from 18 to 70 years old; (3) Duration of the disease exceeding 3 months; (4) Voluntary participation in the trial and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those with secondary facial nerve palsy caused by tumors, trauma, otitis media, mumps, Guillain-Barré syndrome, etc.; (2) Patients with mental disorders or those with severe internal diseases such as diabetes, hypertension, etc.; (3) Pregnant women, lactating women or women planning to conceive; (4) Patients with peripheral facial paralysis accompanied by facial muscle spasms; (5) Patients with a history of epilepsy or a family history of epilepsy; (6) Those with metal implants such as stents, cardiac pacemakers and cochlear implants; (7) Those with infection or skin ulceration at the acupuncture site; (8) Those with contraindications to acupuncture, or those allergic to sterilized items, protein threads, etc.; (9) Those currently participating in other clinical trials that may affect the evaluation of the results of this study.

Design outcomes

Primary

MeasureTime frame
Facial nerve function scoring scale score;

Secondary

MeasureTime frame
Facial Disability Indexs, FDI;Motor evoked potential latency and amplitude;

Countries

China

Contacts

Public ContactWanqing Lin

Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine

13960829639@139.com13960829639

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026